GriffithsE.The control of biological medicinal products produced by recombinant DNA technology. Dev Biol Stand1985; 59: 155–9
2.
Office of Biologics, Research and Review. Points to consider in the manufacture and testing of monoclonal antibody products for human use.Bethesda: Food and Drug Administration, 1987
3.
Office of Biologics, Research and Review. Points to consider in the production and testing of new drugs and biologicals produced by recombinant DNA technology.Bethesda: Food and Drug Administration, 1987
4.
World Health Organization. Quality control of biologicals produced by recombinant DNA techniques. Bull WHO1983; 61: 897–911
5.
World Health Organization. Acceptability of cell substrates for production of biologicals. WHO Tech Rep Ser1987; 747: 3–29
6.
Commission of the European Communities. Notes to applicants for marketing authorizations on the production and quality control of monoclonal antibodies of murine origin intended for use in man. III/859/86-EN, June 1987
7.
Commission of the European Communities. Notes to applicants for marketing authorizations on the production and quality control of medicinal products derived by recombinant DNA technology. III/860/86-EN, June 1987
